Researchers at the University of Surrey are creating immune digital twins, virtual models of individual immune systems, to advance personalised medicine and deliver tailored treatments.
Renata Mala, PharmD, Chairman of Purely Plant GmbH, underlines the importance of ensuring high and reproducible quality when it comes to medicinal cannabis.
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
Researchers at the University of Toronto Engineering tried co-injection of both retinal pigmented epithelium (RPE) cells and photoreceptor cells to reverse vision loss.
Scientists at the University of Cambridge have discovered a genetic variant that acts as a natural epidural, explaining why some women do not need pain relief during childbirth.
EIB and CureVac have signed a €75m loan agreement to develop a large-scale production of vaccines, including CureVac's vaccine candidate against SARS-CoV-2.
Professor Trevor Jones, Chair at the European Medicinal Cannabis Association, speaks to Nishat about their plans for EU patient access to medicinal cannabis.
